New York Times: At 16, she’s a pioneer in the fight to cure sickle cell disease

The New York Times details the journey of Helen Obando, a 16-year-old with sickle cell disease, who is the first adolescent patient to undergo a novel sickle cell gene therapy clinical trial led by Boston Children’s Chief Scientific Officer David Williams, MD, and Erica Esrick, MD. Both Williams and Esrick are featured in the piece, as is Stuart Orkin, MD, and Vijay Sankaran, MD, PhD, whose basic research was instrumental in the development of the treatment. Read more from The New York Times.